Literature DB >> 26220605

Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review.

Kyeore Bae1, Hwa-Seung Yoo2, Gillian Lamoury3, Frances Boyle4, David S Rosenthal5, Byeongsang Oh6.   

Abstract

BACKGROUND: Aromatase inhibitors (AIs) are commonly used as adjunctive hormone treatment for early breast cancer patients. The major side effect of AIs is arthralgia, which affects adherence. Previous reviews suggested that acupuncture is effective in the management of cancer-related pain. The aim of this review is to evaluate the effects of acupuncture on arthralgia caused by AIs.
METHODS: This article examined randomized controlled trials (RCTs) measuring the effects of acupuncture on joint symptoms caused by AIs within 8 medical databases till May 2014. The quality of the articles was evaluated according to the Cochrane risk of bias (ROB) tool.
RESULTS: Four RCTs were identified in medical journals. Two studies were conducted with manual acupuncture and 2 studies were electroacupuncture. The range of sample size was between 32 and 67. One RCT showed significant improvement in the acupuncture group compared with the sham control group and another RCT showed a statistical difference between the electroacupuncture and waitlist group. The other 2 studies showed no statistical differences between control and acupuncture groups. Two studies conducted blood analysis to elucidate the mechanism of efficacy of acupuncture for arthralgia. The 2 positive studies had a lower ROB and 2 studies had a high ROB.
CONCLUSIONS: The systematic review suggests that acupuncture has potential benefits to improve arthralgia caused by AIs. However, further trials of adequate sample size, appropriate control group, and longer follow-up are necessary to investigate the efficacy of acupuncture in AI-induced arthralgia.
© The Author(s) 2015.

Entities:  

Keywords:  acupuncture; aromatase inhibitors; arthralgia; breast cancer; joint pain; pain management

Mesh:

Substances:

Year:  2015        PMID: 26220605     DOI: 10.1177/1534735415596573

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  11 in total

Review 1.  Add-On Complementary Medicine in Cancer Care: Evidence in Literature and Experiences of Integration.

Authors:  Elio Rossi; Mariella Di Stefano; Fabio Firenzuoli; Maria Valeria Monechi; Sonia Baccetti
Journal:  Medicines (Basel)       Date:  2017-01-24

Review 2.  Effectiveness of acupuncture for cancer pain: protocol for an umbrella review and meta-analyses of controlled trials.

Authors:  Yihan He; Yihong Liu; Brian H May; Anthony Lin Zhang; Haibo Zhang; ChuanJian Lu; Lihong Yang; Xinfeng Guo; Charlie Changli Xue
Journal:  BMJ Open       Date:  2017-12-10       Impact factor: 2.692

3.  Ergostane-Type Sterols from King Trumpet Mushroom (Pleurotus eryngii) and Their Inhibitory Effects on Aromatase.

Authors:  Takashi Kikuchi; Naoki Motoyashiki; Takeshi Yamada; Kanae Shibatani; Kiyofumi Ninomiya; Toshio Morikawa; Reiko Tanaka
Journal:  Int J Mol Sci       Date:  2017-11-21       Impact factor: 5.923

Review 4.  The Effects of Pharmacological and Non-Pharmacological Interventions on Symptom Management and Quality of Life among Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy: A Systematic Review.

Authors:  Carmen W H Chan; Daria Tai; Stephanie Kwong; Ka Ming Chow; Dorothy N S Chan; Bernard M H Law
Journal:  Int J Environ Res Public Health       Date:  2020-04-24       Impact factor: 3.390

5.  Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.

Authors:  Yi-Ting Kuo; Tung-Ti Chang; Chih-Hsin Muo; Mei-Yao Wu; Mao-Feng Sun; Chia-Chou Yeh; Hung-Rong Yen
Journal:  Integr Cancer Ther       Date:  2017-06-30       Impact factor: 3.279

6.  Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.

Authors:  Seungwon Shin; Bo-Hyoung Jang; Seung-Hyeok Park; Jin-Wook Lee; Min Soo Chae; Namhoon Kim; Hae Sun Suh; Sola Han; Sun Young Min; Sun Kyung Baek; Yu Jin Lim; Deok-Sang Hwang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 7.  Evidence, safety and recommendations for when to use acupuncture for treating cancer related symptoms: a narrative review.

Authors:  Stephen Birch; Myeong Soo Lee; Terje Alraek; Tae-Hun Kim
Journal:  Integr Med Res       Date:  2019-05-17

8.  Acupuncture for Arthralgia Induced by Aromatase Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis.

Authors:  Xiaomeng Liu; Jing Lu; Guoxin Wang; Xiu Chen; Haiping Xv; Jing Huang; Mingxin Xue; Jinhai Tang
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

Review 9.  The role of complementary and alternative methods in the treatment of pain in patients with cancer - current evidence and clinical practice: a narrative review.

Authors:  Magdalena Kocot-Kępska; Renata Zajączkowska; Jing Zhao; Jerzy Wordliczek; Przemysław J Tomasik; Anna Przeklasa-Muszyńska
Journal:  Contemp Oncol (Pozn)       Date:  2021-05-07

10.  Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients.

Authors:  Sarah G Bell; Liam Dalton; Brendan L McNeish; Fang Fang; N Lynn Henry; Kelley M Kidwell; Karen McLean
Journal:  Gynecol Oncol       Date:  2020-08-23       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.